| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Mar 18, 2025 | Altimmune, Inc. | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $5.8K |
| Aug 11, 2023 | Aug 15, 2023 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,834 | 14.07% | ✗ | $171.5K |
| Aug 5, 2022 | Aug 9, 2022 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,472 | 12.73% | ✗ | $165.9K |
| Aug 6, 2021 | Aug 10, 2021 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -1,306 | -10.15% | ✗ | $193.2K |
| Nov 4, 2020 | Nov 6, 2020 | Jazz Pharmaceuticals plc | Director | Sell | 17.5 | -12,500 | -37.04% | ✗ | $1.9M |
| Aug 6, 2020 | Aug 10, 2020 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,774 | 20.05% | ✗ | $117.2K |
| Oct 4, 2019 | Oct 7, 2019 | LIFECORE BIOMEDICAL, INC. \DE\ | Director | Sell | 22.5 | -8,824 | -22.44% | ✗ | $90.1K |
| Aug 8, 2019 | Aug 12, 2019 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +1,194 | 15.60% | ✗ | $98.5K |
| Jan 10, 2019 | Jan 11, 2019 | LIFECORE BIOMEDICAL, INC. \DE\ | Director | Buy | 83.8 | +1,000 | 4.15% | ✗ | $11.2K |
| Aug 9, 2018 | Aug 13, 2018 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +835 | 12.25% | ✗ | $116.6K |
| Aug 10, 2017 | Aug 14, 2017 | Jazz Pharmaceuticals plc | Director | Sell | 95.0 | +703 | 11.49% | ✗ | $94.2K |
| Aug 15, 2016 | Aug 17, 2016 | Jazz Pharmaceuticals plc | Director | Sell | 22.5 | -633 | -9.38% | ✗ | $86.4K |